Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5V6L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,911
Award facts
- Contract value 100% obligated
- $30,911.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,911.24 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract vehicle, valued up to $999,999,999.00 through December 2031, serves as a comprehensive global pharmaceutical support mechanism enabling delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Dupixent is a biologic immunosuppressant medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions. The supply will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's critical role as a pharmaceutical distributor and healthcare solutions provider within the federal procurement ecosystem, with demonstrated capability to fulfill open competition requirements across multiple therapeutic domains and to efficiently manage specialized medication deliveries for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5V6L?
SPE2DR26F5V6L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F5V6L worth?
The government has obligated $30,911 on SPE2DR26F5V6L.
Is contract SPE2DR26F5V6L an order under another contract?
Yes. SPE2DR26F5V6L is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5V6L competed?
The extent of competition for SPE2DR26F5V6L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award